These results, together with a preceding report demonstrating that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,2 support the strategy of targeting ACKR3 as a novel method to modulate the opioid program, which could open up new therapeutic avenues for opioid-similar Ailments. These success counsel that conolidine https://mitchu044dcp9.blogsumer.com/profile